<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-05-23" modified="2020-10-07" version="193">
<accession>Q8WUM4</accession>
<accession>C5MQH7</accession>
<accession>E9PFU1</accession>
<accession>Q6NUS1</accession>
<accession>Q9BX86</accession>
<accession>Q9NUN0</accession>
<accession>Q9P2H2</accession>
<accession>Q9UKL5</accession>
<name>PDC6I_HUMAN</name>
<protein>
<recommendedName>
<fullName>Programmed cell death 6-interacting protein</fullName>
<shortName>PDCD6-interacting protein</shortName>
</recommendedName>
<alternativeName>
<fullName>ALG-2-interacting protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>ALG-2-interacting protein X</fullName>
</alternativeName>
<alternativeName>
<fullName>Hp95</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PDCD6IP</name>
<name type="synonym">AIP1</name>
<name type="synonym">ALIX</name>
<name type="synonym">KIAA1375</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Differentiation" volume="67" first="139" last="153">
<title>Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells.</title>
<authorList>
<person name="Wu Y."/>
<person name="Pan S."/>
<person name="Che S."/>
<person name="He G."/>
<person name="Nelman-Gonzalez M."/>
<person name="Weil M.M."/>
<person name="Kuang J."/>
</authorList>
<dbReference type="PubMed" id="11683497"/>
<dbReference type="DOI" id="10.1046/j.1432-0436.2001.670406.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-550</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2009" name="BMC Genomics" volume="10" first="518" last="518">
<title>Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site.</title>
<authorList>
<person name="Wang P."/>
<person name="Yu P."/>
<person name="Gao P."/>
<person name="Shi T."/>
<person name="Ma D."/>
</authorList>
<dbReference type="PubMed" id="19906316"/>
<dbReference type="DOI" id="10.1186/1471-2164-10-518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="3">
<citation type="submission" date="1999-05" db="EMBL/GenBank/DDBJ databases">
<title>Molecular cloning of human ALG-2 interacting protein 1 (AIP1).</title>
<authorList>
<person name="Li H."/>
<person name="Shioda T."/>
<person name="Isselbacher K.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS THR-309 AND LEU-730</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANTS MET-7 AND ILE-378</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2008-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Glen H."/>
<person name="Frame M.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-23; 111-120; 216-229; 439-446; 457-469 AND 542-553</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Osteosarcoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 209-868 (ISOFORM 1)</scope>
<scope>VARIANT ILE-378</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="DNA Res." volume="7" first="65" last="73">
<title>Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Ishikawa K."/>
<person name="Hirosawa M."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10718198"/>
<dbReference type="DOI" id="10.1093/dnares/7.1.65"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 323-868 (ISOFORM 1)</scope>
<scope>VARIANT SER-550</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="39104" last="39113">
<title>The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting.</title>
<authorList>
<person name="Katoh K."/>
<person name="Shibata H."/>
<person name="Suzuki H."/>
<person name="Narai A."/>
<person name="Ishidoh K."/>
<person name="Kominami E."/>
<person name="Yoshimori T."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="12860994"/>
<dbReference type="DOI" id="10.1074/jbc.m301604200"/>
</citation>
<scope>INTERACTION WITH CHMP4A AND CHMP4B</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Cell" volume="114" first="689" last="699">
<title>AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.</title>
<authorList>
<person name="Strack B."/>
<person name="Calistri A."/>
<person name="Craig S."/>
<person name="Popova E."/>
<person name="Goettlinger H.G."/>
</authorList>
<dbReference type="PubMed" id="14505569"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00653-6"/>
</citation>
<scope>FUNCTION IN HIV-1 BUDDING (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH CHMP4A; CHMP4B AND CHMP4C</scope>
<scope>INTERACTION WITH HIV-1 P6 AND EIAV P9 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Cell" volume="114" first="701" last="713">
<title>The protein network of HIV budding.</title>
<authorList>
<person name="von Schwedler U.K."/>
<person name="Stuchell M."/>
<person name="Mueller B."/>
<person name="Ward D.M."/>
<person name="Chung H.-Y."/>
<person name="Morita E."/>
<person name="Wang H.E."/>
<person name="Davis T."/>
<person name="He G.P."/>
<person name="Cimbora D.M."/>
<person name="Scott A."/>
<person name="Kraeusslich H.-G."/>
<person name="Kaplan J."/>
<person name="Morham S.G."/>
<person name="Sundquist W.I."/>
</authorList>
<dbReference type="PubMed" id="14505570"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00714-1"/>
</citation>
<scope>FUNCTION IN HIV-1 BUDDING (MICROBIAL INFECTION)</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>INTERACTION WITH TSG101; CHMP4A; CHMP4B CHMP4C</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="12414" last="12419">
<title>Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.</title>
<authorList>
<person name="Martin-Serrano J."/>
<person name="Yarovoy A."/>
<person name="Perez-Caballero D."/>
<person name="Bieniasz P.D."/>
</authorList>
<dbReference type="PubMed" id="14519844"/>
<dbReference type="DOI" id="10.1073/pnas.2133846100"/>
</citation>
<scope>SELF-ASSOCIATION</scope>
<scope>INTERACTION WITH TSG101; CHMP4A; CHMP4B AND CHMP4C</scope>
<scope>INTERACTION WITH EIAV P9 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="152845" last="152845">
<authorList>
<person name="Martin-Serrano J."/>
<person name="Yarovoy A."/>
<person name="Perez-Caballero D."/>
<person name="Bieniasz P.D."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:14519844</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Arch. Biochem. Biophys." volume="421" first="159" last="165">
<title>CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms.</title>
<authorList>
<person name="Katoh K."/>
<person name="Shibata H."/>
<person name="Hatta K."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="14678797"/>
<dbReference type="DOI" id="10.1016/j.abb.2003.09.038"/>
</citation>
<scope>INTERACTION WITH CHMP4A; CHMP4B AND CHMP4C</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Biochem. J." volume="377" first="693" last="700">
<title>Structure and function of human Vps20 and Snf7 proteins.</title>
<authorList>
<person name="Peck J.W."/>
<person name="Bowden E.T."/>
<person name="Burbelo P.D."/>
</authorList>
<dbReference type="PubMed" id="14583093"/>
<dbReference type="DOI" id="10.1042/bj20031347"/>
</citation>
<scope>INTERACTION WITH CHMP4A; CHMP4B AND CHMP4C</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Science" volume="303" first="531" last="534">
<title>Role of LBPA and Alix in multivesicular liposome formation and endosome organization.</title>
<authorList>
<person name="Matsuo H."/>
<person name="Chevallier J."/>
<person name="Mayran N."/>
<person name="Le Blanc I."/>
<person name="Ferguson C."/>
<person name="Faure J."/>
<person name="Blanc N.S."/>
<person name="Matile S."/>
<person name="Dubochet J."/>
<person name="Sadoul R."/>
<person name="Parton R.G."/>
<person name="Vilbois F."/>
<person name="Gruenberg J."/>
</authorList>
<dbReference type="PubMed" id="14739459"/>
<dbReference type="DOI" id="10.1126/science.1092425"/>
</citation>
<scope>FUNCTION IN ENDOSOME ORGANIZATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Biosci. Biotechnol. Biochem." volume="69" first="861" last="865">
<title>Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.</title>
<authorList>
<person name="Ichioka F."/>
<person name="Horii M."/>
<person name="Katoh K."/>
<person name="Terasawa Y."/>
<person name="Shibata H."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="15849434"/>
<dbReference type="DOI" id="10.1271/bbb.69.861"/>
</citation>
<scope>INTERACTION WITH SGSM3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="27004" last="27012">
<title>Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding.</title>
<authorList>
<person name="Segura-Morales C."/>
<person name="Pescia C."/>
<person name="Chatellard-Causse C."/>
<person name="Sadoul R."/>
<person name="Bertrand E."/>
<person name="Basyuk E."/>
</authorList>
<dbReference type="PubMed" id="15908698"/>
<dbReference type="DOI" id="10.1074/jbc.m413735200"/>
</citation>
<scope>INTERACTION WITH MURINE LEUKEMIA VIRUS GAG POLYPROTEIN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="4876" last="4887">
<title>The Ca2+-binding protein ALG-2 is recruited to endoplasmic reticulum exit sites by Sec31A and stabilizes the localization of Sec31A.</title>
<authorList>
<person name="Yamasaki A."/>
<person name="Tani K."/>
<person name="Yamamoto A."/>
<person name="Kitamura N."/>
<person name="Komada M."/>
</authorList>
<dbReference type="PubMed" id="16957052"/>
<dbReference type="DOI" id="10.1091/mbc.e06-05-0444"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH PDCD6</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="4215" last="4227">
<title>Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis.</title>
<authorList>
<person name="Morita E."/>
<person name="Sandrin V."/>
<person name="Chung H.Y."/>
<person name="Morham S.G."/>
<person name="Gygi S.P."/>
<person name="Rodesch C.K."/>
<person name="Sundquist W.I."/>
</authorList>
<dbReference type="PubMed" id="17853893"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601850"/>
</citation>
<scope>FUNCTION IN CYTOKINESIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CEP55 AND CD2AP</scope>
<scope>MUTAGENESIS OF ILE-212; PHE-676 AND 800-GLY--PRO-802</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="J. Virol." volume="81" first="6614" last="6622">
<title>Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site.</title>
<authorList>
<person name="Usami Y."/>
<person name="Popov S."/>
<person name="Goettlinger H.G."/>
</authorList>
<dbReference type="PubMed" id="17428861"/>
<dbReference type="DOI" id="10.1128/jvi.00314-07"/>
</citation>
<scope>FUNCTION IN HIV-1 BUDDING (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH CHMP4B</scope>
<scope>MUTAGENESIS OF PHE-199; LEU-216; PHE-317; ILE-318 AND TYR-319</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Science" volume="316" first="1908" last="1912">
<title>Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery.</title>
<authorList>
<person name="Carlton J.G."/>
<person name="Martin-Serrano J."/>
</authorList>
<dbReference type="PubMed" id="17556548"/>
<dbReference type="DOI" id="10.1126/science.1143422"/>
</citation>
<scope>FUNCTION IN CYTOKINESIS AND HIV1 RELEASE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CEP55</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="9623" last="9632">
<title>Identification of Alix-type and non-Alix-type ALG-2-binding sites in human phospholipid scramblase 3: differential binding to an alternatively spliced isoform and amino acid-substituted mutants.</title>
<authorList>
<person name="Shibata H."/>
<person name="Suzuki H."/>
<person name="Kakiuchi T."/>
<person name="Inuzuka T."/>
<person name="Yoshida H."/>
<person name="Mizuno T."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="18256029"/>
<dbReference type="DOI" id="10.1074/jbc.m800717200"/>
</citation>
<scope>INTERACTION WITH PDCD6</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10541" last="10546">
<title>Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release.</title>
<authorList>
<person name="Carlton J.G."/>
<person name="Agromayor M."/>
<person name="Martin-Serrano J."/>
</authorList>
<dbReference type="PubMed" id="18641129"/>
<dbReference type="DOI" id="10.1073/pnas.0802008105"/>
</citation>
<scope>FUNCTION IN CYTOKINESIS AND HIV1 RELEASE</scope>
<scope>INTERACTION WITH CEP55 AND TSG101</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PHE-199; ILE-212; PHE-676; 717-PRO--PRO-720; 744-PRO-ARG-745; 757-ARG--PRO-759; 794-PRO--CYS-813; 801-PRO-PRO-802; 803-TYR-PRO-804; 805-THR-TYR-806; 852-PRO--PRO-855 AND 864-TYR-TYR-865</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-730; THR-738 AND THR-741</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="386" first="237" last="241">
<title>Penta-EF-hand protein ALG-2 functions as a Ca2+-dependent adaptor that bridges Alix and TSG101.</title>
<authorList>
<person name="Okumura M."/>
<person name="Ichioka F."/>
<person name="Kobayashi R."/>
<person name="Suzuki H."/>
<person name="Yoshida H."/>
<person name="Shibata H."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="19520058"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.06.015"/>
</citation>
<scope>INTERACTION WITH TSG101</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-215</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Cell. Signal." volume="22" first="1363" last="1368">
<title>Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.</title>
<authorList>
<person name="Wardega P."/>
<person name="Heldin C.H."/>
<person name="Lennartsson J."/>
</authorList>
<dbReference type="PubMed" id="20494825"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.05.004"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PDGFRB</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-738 AND THR-741</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="3546" last="3556">
<title>Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding.</title>
<authorList>
<person name="Rauch S."/>
<person name="Martin-Serrano J."/>
</authorList>
<dbReference type="PubMed" id="21191027"/>
<dbReference type="DOI" id="10.1128/jvi.02045-10"/>
</citation>
<scope>INTERACTION WITH ARRDC1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Nat. Cell Biol." volume="14" first="677" last="685">
<title>Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.</title>
<authorList>
<person name="Baietti M.F."/>
<person name="Zhang Z."/>
<person name="Mortier E."/>
<person name="Melchior A."/>
<person name="Degeest G."/>
<person name="Geeraerts A."/>
<person name="Ivarsson Y."/>
<person name="Depoortere F."/>
<person name="Coomans C."/>
<person name="Vermeiren E."/>
<person name="Zimmermann P."/>
<person name="David G."/>
</authorList>
<dbReference type="PubMed" id="22660413"/>
<dbReference type="DOI" id="10.1038/ncb2502"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SDCBP AND SDC2</scope>
<scope>MUTAGENESIS OF PHE-676</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-479 AND SER-481</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-745</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="J. Infect. Dis." volume="212" first="S138" last="S145">
<title>ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.</title>
<authorList>
<person name="Han Z."/>
<person name="Madara J.J."/>
<person name="Liu Y."/>
<person name="Liu W."/>
<person name="Ruthel G."/>
<person name="Freedman B.D."/>
<person name="Harty R.N."/>
</authorList>
<dbReference type="PubMed" id="25786915"/>
<dbReference type="DOI" id="10.1093/infdis/jiu838"/>
</citation>
<scope>INTERACTION WITH EBOLA VIRUS PROTEIN VP40 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="Cell" volume="128" first="841" last="852">
<title>Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding.</title>
<authorList>
<person name="Fisher R.D."/>
<person name="Chung H.Y."/>
<person name="Zhai Q."/>
<person name="Robinson H."/>
<person name="Sundquist W.I."/>
<person name="Hill C.P."/>
</authorList>
<dbReference type="PubMed" id="17350572"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.01.035"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 1-698</scope>
<scope>INTERACTION WITH CHMP4A; HIV-1 P6; EIAV P9; TSG101; SH3GL1 AND SH3GL2</scope>
<scope>MUTAGENESIS OF ILE-212; TYR-319; PHE-495; VAL-498; VAL-509; PHE-676; LEU-680; ILE-683; PRO-720 AND 757-ARG-PRO-758</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="194" last="199">
<title>Structural basis for viral late-domain binding to Alix.</title>
<authorList>
<person name="Lee S."/>
<person name="Joshi A."/>
<person name="Nagashima K."/>
<person name="Freed E.O."/>
<person name="Hurley J.H."/>
</authorList>
<dbReference type="PubMed" id="17277784"/>
<dbReference type="DOI" id="10.1038/nsmb1203"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 360-702</scope>
<scope>INTERACTION WITH HIV-1 P6</scope>
<scope>MUTAGENESIS OF VAL-498; VAL-509; CYS-512; PHE-676 AND ILE-683</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Nat. Struct. Mol. Biol." volume="15" first="43" last="49">
<title>Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV.</title>
<authorList>
<person name="Zhai Q."/>
<person name="Fisher R.D."/>
<person name="Chung H.Y."/>
<person name="Myszka D.G."/>
<person name="Sundquist W.I."/>
<person name="Hill C.P."/>
</authorList>
<dbReference type="PubMed" id="18066081"/>
<dbReference type="DOI" id="10.1038/nsmb1319"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 2-698 IN COMPLEX WITH HIV-1 P6</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 2-698 IN COMPLEX WITH HIV-1 P9</scope>
<scope>INTERACTION WITH EIAV P9</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="7687" last="7691">
<title>ALIX-CHMP4 interactions in the human ESCRT pathway.</title>
<authorList>
<person name="McCullough J."/>
<person name="Fisher R.D."/>
<person name="Whitby F.G."/>
<person name="Sundquist W.I."/>
<person name="Hill C.P."/>
</authorList>
<dbReference type="PubMed" id="18511562"/>
<dbReference type="DOI" id="10.1073/pnas.0801567105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 1-359 IN COMPLEX WITH CHMP4A</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-359 IN COMPLEX WITH CHMP4B</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 1-359 IN COMPLEX WITH CHMP4C</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Science" volume="322" first="576" last="580">
<title>Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55.</title>
<authorList>
<person name="Lee H.H."/>
<person name="Elia N."/>
<person name="Ghirlando R."/>
<person name="Lippincott-Schwartz J."/>
<person name="Hurley J.H."/>
</authorList>
<dbReference type="PubMed" id="18948538"/>
<dbReference type="DOI" id="10.1126/science.1162042"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 797-809 IN COMPLEX WITH CEP55</scope>
<scope>MUTAGENESIS OF PRO-801; PRO-802 AND TYR-806</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Structure" volume="16" first="1562" last="1573">
<title>Structural basis for Ca2+ -dependent formation of ALG-2/Alix peptide complex: Ca2+/EF3-driven arginine switch mechanism.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Kawasaki M."/>
<person name="Inuzuka T."/>
<person name="Okumura M."/>
<person name="Kakiuchi T."/>
<person name="Shibata H."/>
<person name="Wakatsuki S."/>
<person name="Maki M."/>
</authorList>
<dbReference type="PubMed" id="18940611"/>
<dbReference type="DOI" id="10.1016/j.str.2008.07.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 799-812 IN COMPLEX WITH PDCD6</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E26741" last="E26741">
<title>Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis.</title>
<authorList>
<person name="Benitez B.A."/>
<person name="Alvarado D."/>
<person name="Cai Y."/>
<person name="Mayo K."/>
<person name="Chakraverty S."/>
<person name="Norton J."/>
<person name="Morris J.C."/>
<person name="Sands M.S."/>
<person name="Goate A."/>
<person name="Cruchaga C."/>
</authorList>
<dbReference type="PubMed" id="22073189"/>
<dbReference type="DOI" id="10.1371/journal.pone.0026741"/>
</citation>
<scope>VARIANT SER-429</scope>
</reference>
<comment type="function">
<text evidence="18 29 38 39 43 50">Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes (PubMed:14739459). The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (PubMed:17853893, PubMed:17556548). Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis (PubMed:17853893, PubMed:17556548, PubMed:18641129). May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP (PubMed:22660413). By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier (By similarity).</text>
</comment>
<comment type="function">
<text evidence="23 24 25 38 43">(Microbial infection) Involved in HIV-1 virus budding. Can replace TSG101 it its role of supporting HIV-1 release; this function requires the interaction with CHMP4B. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as enveloped virus budding (HIV-1 and other lentiviruses).</text>
</comment>
<comment type="subunit">
<text evidence="17 18 22 23 24 25 26 27 31 33 36 37 38 39 41 42 43 44 45 46 47 48 50">Self-associates (PubMed:14505570, PubMed:14519844). Interacts with SH3KBP1/CIN85 (By similarity). Interacts with PDCD6 in a calcium -dependent manner (PubMed:16957052, PubMed:18256029, PubMed:18940611). Interacts with TSG101 in a calcium-dependent manner; PDCD6IP homooligomerization may be required for TSG101-binding (PubMed:14505570, PubMed:14519844, PubMed:18641129, PubMed:19520058, PubMed:17350572). Interacts with SGSM3 (PubMed:15849434). Directly interacts with CHMP4A, CHMP4B and CHMP4C (PubMed:12860994, PubMed:14505569, PubMed:14505570, PubMed:14519844, PubMed:14678797, PubMed:14583093, PubMed:17428861, PubMed:17350572, PubMed:18511562). Directly interacts with CEP55 in a 1:2 stoechiometry (PubMed:17853893, PubMed:17556548, PubMed:18641129, PubMed:18948538). The interaction with CEP55 is required for PDCD6IP targeting to the midbody (PubMed:18641129). May interact with PDGFRB (PubMed:20494825). Interacts with SH3GL1 and SH3GL2/endophilin-1 (PubMed:17350572). Forms a complex with SDCBP and SDC2 (PubMed:22660413). Found in a complex with F-actin, TJP1/ZO-1 and PARD3 (By similarity). Interacts with CD2AP (PubMed:17853893). Interacts with ARRDC1 (PubMed:21191027).</text>
</comment>
<comment type="subunit">
<text evidence="23 25 35 36 40">(Microbial infection) Interacts with HIV-1 p6 (PubMed:14505569, PubMed:17350572, PubMed:17277784, PubMed:18066081). Interacts with HIV-1 p9 (PubMed:18066081).</text>
</comment>
<comment type="subunit">
<text evidence="23 25 36 40">(Microbial infection) Interacts with EIAV p9.</text>
</comment>
<comment type="subunit">
<text evidence="32">(Microbial infection) Interacts with Murine leukemia virus Gag polyprotein (via LYPX(n)L motif).</text>
</comment>
<comment type="subunit">
<text evidence="32">(Microbial infection) Interacts with ebola virus protein VP40 (via YPx(n)L/I motif).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-298152">
<id>Q9Y5K6</id>
<label>CD2AP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-747776">
<id>Q53EZ4</id>
<label>CEP55</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-747981">
<id>Q9BY43</id>
<label>CHMP4A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-749627">
<id>Q9H444</id>
<label>CHMP4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-1221015">
<id>Q96CF2</id>
<label>CHMP4C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-1170392">
<id>P17931</id>
<label>LGALS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-352915">
<id>O75340</id>
<label>PDCD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-8322817">
<id>Q9D8B3</id>
<label>Chmp4b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-1220741">
<id>P03347</id>
<label>gag</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-1220941">
<id>P69730</id>
<label>gag</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-3957603">
<id>P09022</id>
<label>Hoxa1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-7460704">
<id>Q90VU7</id>
<label>nef</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
</interactant>
<interactant intactId="EBI-8826747">
<id>PRO_0000308465</id>
<dbReference type="UniProtKB" id="P29991"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
<location evidence="17">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="34">Melanosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="38 39">Cytoplasm</location>
<location evidence="38 39">Cytoskeleton</location>
<location evidence="38 39">Microtubule organizing center</location>
<location evidence="38 39">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="50">Secreted</location>
<location evidence="50">Extracellular exosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Cell junction</location>
<location evidence="18">Tight junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="39 43">Midbody</location>
<location evidence="39 43">Midbody ring</location>
</subcellularLocation>
<text evidence="17 18 34 38 39 43">Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Colocalized with CEP55 at centrosomes of non-dividing cells. Component of the actomyosin-tight junction complex (By similarity). PDCD6IP targeting to the midbody requires the interaction with CEP55 (PubMed:18641129).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8WUM4-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8WUM4-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044860"/>
</isoform>
<isoform>
<id>Q8WUM4-3</id>
<name>3</name>
<sequence type="described" ref="VSP_057190 VSP_057191"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="47">May be phosphorylated on tyrosine residues by activated PDGFRB.</text>
</comment>
<comment type="sequence caution" evidence="55">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA92092" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EMBL" id="AF349951">
<property type="protein sequence ID" value="AAK20398.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ131806">
<property type="protein sequence ID" value="ACS12984.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF151793">
<property type="protein sequence ID" value="AAF08220.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007367">
<property type="protein sequence ID" value="AAP36031.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC112220">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC123901">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020066">
<property type="protein sequence ID" value="AAH20066.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC068454">
<property type="protein sequence ID" value="AAH68454.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK002122">
<property type="protein sequence ID" value="BAA92092.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB037796">
<property type="protein sequence ID" value="BAA92613.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2660.1">
<molecule id="Q8WUM4-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54561.1">
<molecule id="Q8WUM4-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001155901.1">
<molecule id="Q8WUM4-2"/>
<property type="nucleotide sequence ID" value="NM_001162429.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243121.1">
<molecule id="Q8WUM4-3"/>
<property type="nucleotide sequence ID" value="NM_001256192.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_037506.2">
<molecule id="Q8WUM4-1"/>
<property type="nucleotide sequence ID" value="NM_013374.5"/>
</dbReference>
<dbReference type="PDB" id="2OEV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=1-698"/>
</dbReference>
<dbReference type="PDB" id="2OEW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=1-359"/>
</dbReference>
<dbReference type="PDB" id="2OEX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B=360-702"/>
</dbReference>
<dbReference type="PDB" id="2OJQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.87"/>
<property type="chains" value="A=360-702"/>
</dbReference>
<dbReference type="PDB" id="2R02">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=2-698"/>
</dbReference>
<dbReference type="PDB" id="2R03">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="A=2-698"/>
</dbReference>
<dbReference type="PDB" id="2R05">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=2-698"/>
</dbReference>
<dbReference type="PDB" id="2XS1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-698"/>
</dbReference>
<dbReference type="PDB" id="2XS8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-698"/>
</dbReference>
<dbReference type="PDB" id="2ZNE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C/D=799-812"/>
</dbReference>
<dbReference type="PDB" id="3C3O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1-359"/>
</dbReference>
<dbReference type="PDB" id="3C3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-359"/>
</dbReference>
<dbReference type="PDB" id="3C3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=1-359"/>
</dbReference>
<dbReference type="PDB" id="3E1R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=797-809"/>
</dbReference>
<dbReference type="PDB" id="3WUV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="C/F/I/L/O/R=796-810"/>
</dbReference>
<dbReference type="PDB" id="4JJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="6.50"/>
<property type="chains" value="A/B=355-708"/>
</dbReference>
<dbReference type="PDB" id="5V3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=1-359"/>
</dbReference>
<dbReference type="PDB" id="5WA1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=1-358"/>
</dbReference>
<dbReference type="PDBsum" id="2OEV"/>
<dbReference type="PDBsum" id="2OEW"/>
<dbReference type="PDBsum" id="2OEX"/>
<dbReference type="PDBsum" id="2OJQ"/>
<dbReference type="PDBsum" id="2R02"/>
<dbReference type="PDBsum" id="2R03"/>
<dbReference type="PDBsum" id="2R05"/>
<dbReference type="PDBsum" id="2XS1"/>
<dbReference type="PDBsum" id="2XS8"/>
<dbReference type="PDBsum" id="2ZNE"/>
<dbReference type="PDBsum" id="3C3O"/>
<dbReference type="PDBsum" id="3C3Q"/>
<dbReference type="PDBsum" id="3C3R"/>
<dbReference type="PDBsum" id="3E1R"/>
<dbReference type="PDBsum" id="3WUV"/>
<dbReference type="PDBsum" id="4JJY"/>
<dbReference type="PDBsum" id="5V3R"/>
<dbReference type="PDBsum" id="5WA1"/>
<dbReference type="SMR" id="Q8WUM4"/>
<dbReference type="BioGRID" id="115332">
<property type="interactions" value="147"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3282">
<property type="entry name" value="Syndecan-1-syntenin-1-ALIX complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-29327N"/>
<dbReference type="IntAct" id="Q8WUM4">
<property type="interactions" value="73"/>
</dbReference>
<dbReference type="MINT" id="Q8WUM4"/>
<dbReference type="STRING" id="9606.ENSP00000411825"/>
<dbReference type="MoonDB" id="Q8WUM4">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="iPTMnet" id="Q8WUM4"/>
<dbReference type="MetOSite" id="Q8WUM4"/>
<dbReference type="PhosphoSitePlus" id="Q8WUM4"/>
<dbReference type="SwissPalm" id="Q8WUM4"/>
<dbReference type="BioMuta" id="PDCD6IP"/>
<dbReference type="DMDM" id="31076831"/>
<dbReference type="UCD-2DPAGE" id="Q8WUM4"/>
<dbReference type="CPTAC" id="CPTAC-419"/>
<dbReference type="CPTAC" id="CPTAC-420"/>
<dbReference type="EPD" id="Q8WUM4"/>
<dbReference type="jPOST" id="Q8WUM4"/>
<dbReference type="MassIVE" id="Q8WUM4"/>
<dbReference type="MaxQB" id="Q8WUM4"/>
<dbReference type="PaxDb" id="Q8WUM4"/>
<dbReference type="PeptideAtlas" id="Q8WUM4"/>
<dbReference type="PRIDE" id="Q8WUM4"/>
<dbReference type="ProteomicsDB" id="20178"/>
<dbReference type="ProteomicsDB" id="74695">
<molecule id="Q8WUM4-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="2777">
<property type="antibodies" value="362 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10015"/>
<dbReference type="Ensembl" id="ENST00000307296">
<molecule id="Q8WUM4-1"/>
<property type="protein sequence ID" value="ENSP00000307387"/>
<property type="gene ID" value="ENSG00000170248"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000457054">
<molecule id="Q8WUM4-2"/>
<property type="protein sequence ID" value="ENSP00000411825"/>
<property type="gene ID" value="ENSG00000170248"/>
</dbReference>
<dbReference type="GeneID" id="10015"/>
<dbReference type="KEGG" id="hsa:10015"/>
<dbReference type="UCSC" id="uc003cfx.5">
<molecule id="Q8WUM4-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10015"/>
<dbReference type="DisGeNET" id="10015"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000170248.13"/>
<dbReference type="GeneCards" id="PDCD6IP"/>
<dbReference type="HGNC" id="HGNC:8766">
<property type="gene designation" value="PDCD6IP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000170248">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="608074">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8WUM4"/>
<dbReference type="OpenTargets" id="ENSG00000170248"/>
<dbReference type="PharmGKB" id="PA33116"/>
<dbReference type="eggNOG" id="KOG2220">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214627"/>
<dbReference type="HOGENOM" id="CLU_007181_2_0_1"/>
<dbReference type="InParanoid" id="Q8WUM4"/>
<dbReference type="KO" id="K12200"/>
<dbReference type="OMA" id="TKYDQHP"/>
<dbReference type="OrthoDB" id="550620at2759"/>
<dbReference type="PhylomeDB" id="Q8WUM4"/>
<dbReference type="TreeFam" id="TF323502"/>
<dbReference type="PathwayCommons" id="Q8WUM4"/>
<dbReference type="Reactome" id="R-HSA-162588">
<property type="pathway name" value="Budding and maturation of HIV virion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5210891">
<property type="pathway name" value="Uptake and function of anthrax toxins"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="10015">
<property type="hits" value="211 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PDCD6IP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q8WUM4"/>
<dbReference type="GeneWiki" id="PDCD6IP"/>
<dbReference type="GenomeRNAi" id="10015"/>
<dbReference type="Pharos" id="Q8WUM4">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8WUM4"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q8WUM4">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000170248">
<property type="expression patterns" value="Expressed in corpus callosum and 238 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8WUM4">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8WUM4">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0042641">
<property type="term" value="C:actomyosin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070971">
<property type="term" value="C:endoplasmic reticulum exit site"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090543">
<property type="term" value="C:Flemming body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001772">
<property type="term" value="C:immunological synapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048306">
<property type="term" value="F:calcium-dependent protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031871">
<property type="term" value="F:proteinase activated receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000915">
<property type="term" value="P:actomyosin contractile ring assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070830">
<property type="term" value="P:bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045199">
<property type="term" value="P:maintenance of epithelial cell apical/basal polarity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061952">
<property type="term" value="P:midbody abscission"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000281">
<property type="term" value="P:mitotic cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036258">
<property type="term" value="P:multivesicular body assembly"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903543">
<property type="term" value="P:positive regulation of exosomal secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903553">
<property type="term" value="P:positive regulation of extracellular exosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0010824">
<property type="term" value="P:regulation of centrosome duplication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903551">
<property type="term" value="P:regulation of extracellular exosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090559">
<property type="term" value="P:regulation of membrane permeability"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090611">
<property type="term" value="P:ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046755">
<property type="term" value="P:viral budding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039702">
<property type="term" value="P:viral budding via host ESCRT complex"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019058">
<property type="term" value="P:viral life cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.280">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR025304">
<property type="entry name" value="ALIX_V_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004328">
<property type="entry name" value="BRO1_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR038499">
<property type="entry name" value="BRO1_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF13949">
<property type="entry name" value="ALIX_LYPXL_bnd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03097">
<property type="entry name" value="BRO1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01041">
<property type="entry name" value="BRO1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51180">
<property type="entry name" value="BRO1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0796">Tight junction</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="initiator methionine" description="Removed" evidence="10 13 16 52">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Programmed cell death 6-interacting protein" id="PRO_0000218891">
<location>
<begin position="2"/>
<end position="868"/>
</location>
</feature>
<feature type="domain" description="BRO1" evidence="19">
<location>
<begin position="3"/>
<end position="392"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with EIAV p9">
<location>
<begin position="176"/>
<end position="868"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CHMP4A, CHMP4B and CHMP4C">
<location>
<begin position="176"/>
<end position="503"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SDCBP" evidence="50">
<location>
<begin position="418"/>
<end position="868"/>
</location>
</feature>
<feature type="region of interest" description="Self-association">
<location>
<begin position="503"/>
<end position="868"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TSG101">
<location>
<begin position="717"/>
<end position="720"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CEP55" evidence="43">
<location>
<begin position="801"/>
<end position="806"/>
</location>
</feature>
<feature type="region of interest" description="Essential to promote virus budding">
<location>
<begin position="864"/>
<end position="868"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="717"/>
<end position="860"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="10 13 16 52">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="479"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="730"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 12">
<location>
<position position="738"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 12">
<location>
<position position="741"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="15">
<location>
<position position="745"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044860" evidence="53">
<original>K</original>
<variation>KYFYFQ</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057190" evidence="54">
<original>EVFPVLAAKHCIMQANAEYHQSILAKQQKKFG</original>
<variation>VSYCFYKHLLTLHVKYLDFFVYKKQVETYKEI</variation>
<location>
<begin position="240"/>
<end position="271"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057191" evidence="54">
<location>
<begin position="272"/>
<end position="868"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11554560." id="VAR_068975" evidence="30">
<original>V</original>
<variation>M</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3792594." id="VAR_053017" evidence="51">
<original>A</original>
<variation>T</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3203777." id="VAR_053018" evidence="28 30">
<original>V</original>
<variation>I</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs76608858." id="VAR_069765" evidence="49">
<original>G</original>
<variation>S</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9813017." id="VAR_053019" evidence="20 21">
<original>N</original>
<variation>S</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3183982." id="VAR_053020">
<original>K</original>
<variation>E</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1127732." id="VAR_024381" evidence="51">
<original>S</original>
<variation>L</variation>
<location>
<position position="730"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not support cytokinesis; loss of normal midbody formation; loss of CHMP4A-, CHMP4B- and CHMP4C-binding in a yeast two-hybrid assay; no effect on localization to the midbody; abolishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="37 43">
<original>F</original>
<variation>D</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not support cytokinesis; loss of normal midbody formation; loss of CHMP4A-, CHMP4B- and CHMP4C-binding in a yeast two-hybrid assay; impairs rescue of PTAP-type L domain-deficient HIV-1 p6; no effect on localization to the midbody." evidence="36 39 43">
<original>I</original>
<variation>D</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CHMP4B and abolishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="37">
<original>L</original>
<variation>D</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="37">
<original>F</original>
<variation>A</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly diminishes rescue of PTAP-type L domain--deficient HIV-1 p6." evidence="37">
<original>I</original>
<variation>A</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly diminishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36 37">
<original>Y</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36 37">
<original>Y</original>
<variation>F</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36">
<original>F</original>
<variation>D</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with HIV-1 p6 and EIAV p9; abolishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="35 36">
<original>V</original>
<variation>D</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with HIV-1 p6; impairs rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="35 36">
<original>V</original>
<variation>D</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with HIV-1 p6; impairs rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="35">
<original>C</original>
<variation>A</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with SDCBP." evidence="50">
<original>F</original>
<variation>A</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with HIV-1 p6 and EIAV p9; abolishes rescue of PTAP-type L domain-deficient HIV-1 p6; no effect on cytokinesis, nor on midbody formation." evidence="35 36 39 43">
<original>F</original>
<variation>D</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36">
<original>L</original>
<variation>D</variation>
<location>
<position position="680"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with HIV-1 p6." evidence="35 36">
<original>I</original>
<variation>A</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with HIV-1 p6 and EIAV p9; abolishes rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="35 36">
<original>I</original>
<variation>D</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on midbody formation, nor on cytokinesis; reduced TSG101-binding; no effect on HIV-1 release. Almost complete loss of TSG101-binding and impaired cytokinesis; when associated with 852-A--A-855." evidence="43">
<original>PSAP</original>
<variation>AAAA</variation>
<location>
<begin position="717"/>
<end position="720"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with TSG101; no effect on rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36">
<original>P</original>
<variation>L</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on midbody formation; loss of CD2AP- and SH3KBP1-binding in a yeast two-hybrid assay; no effect on HIV-1 release." evidence="43">
<original>PR</original>
<variation>VD</variation>
<location>
<begin position="744"/>
<end position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on midbody formation; loss of SH3GL2-binding in a yeast two-hybrid assay." evidence="43">
<original>RPP</original>
<variation>GAA</variation>
<location>
<begin position="757"/>
<end position="759"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SH3GL1 and SH3GL2; no effect on rescue of PTAP-type L domain-deficient HIV-1 p6." evidence="36">
<original>RP</original>
<variation>AA</variation>
<location>
<begin position="757"/>
<end position="758"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not support the formation of normal midbodies; loss of localization to the midbody; loss of CD2AP-, CEP55-, SH3GL2-, SH3KBP1-, TSG101-binding in a yeast two-hybrid assay." evidence="43">
<location>
<begin position="794"/>
<end position="813"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CEP55; inhibits support of cytokinesis." evidence="39">
<original>GPP</original>
<variation>AAA</variation>
<location>
<begin position="800"/>
<end position="802"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of midbody localization; does not support cytokinesis; loss of CEP55-binding in a yeast two-hybrid assay; no effect on HIV-1 release." evidence="43">
<original>PP</original>
<variation>VD</variation>
<location>
<begin position="801"/>
<end position="802"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with CEP55." evidence="45">
<original>P</original>
<variation>A</variation>
<location>
<position position="801"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with CEP55." evidence="45">
<original>P</original>
<variation>A</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on CEP55-binding in a yeast two-hybrid assay." evidence="43">
<original>YP</original>
<variation>VD</variation>
<location>
<begin position="803"/>
<end position="804"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of CEP55-binding in a yeast two-hybrid assay." evidence="43">
<original>TY</original>
<variation>VD</variation>
<location>
<begin position="805"/>
<end position="806"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CEP55." evidence="45">
<original>Y</original>
<variation>A</variation>
<location>
<position position="806"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of homoologimerization and reduced TSG101-binding; decreased HIV-1 release; no effect on cytokinesis. Almost complete loss of TSG101-binding and impaired cytokinesis; when associated with 717-A--A-720." evidence="43">
<original>PSYP</original>
<variation>ASAA</variation>
<location>
<begin position="852"/>
<end position="855"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of homooligomerization; reduced TSG101-binding; impaired HIV-1 release." evidence="43">
<original>YY</original>
<variation>AA</variation>
<location>
<begin position="864"/>
<end position="865"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; BAA92092." ref="8" evidence="55">
<original>M</original>
<variation>T</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="18"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="32"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="35"/>
<end position="54"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="62"/>
<end position="76"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="77"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="93"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="98"/>
<end position="100"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="110"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="116"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="143"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="181"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="210"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="241"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="270"/>
<end position="290"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="292"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="298"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="348"/>
<end position="350"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="354"/>
<end position="357"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="361"/>
<end position="398"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="399"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="403"/>
<end position="406"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="408"/>
<end position="412"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="415"/>
<end position="426"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="427"/>
<end position="429"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="430"/>
<end position="471"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="473"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="481"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="517"/>
<end position="523"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="527"/>
<end position="532"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="547"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="581"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="591"/>
<end position="593"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="596"/>
<end position="639"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="644"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="802"/>
<end position="805"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="810"/>
<end position="813"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OEV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2R05"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XS1"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ZNE"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3C3R"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3E1R"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V3R"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WA1"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QZA2"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9WU78"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00526"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10718198"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11683497"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12860994"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14505569"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14505570"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14519844"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14583093"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14678797"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739459"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15849434"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15908698"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16957052"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081065"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17277784"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17350572"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17428861"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17556548"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17853893"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18066081"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18256029"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18511562"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18641129"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18940611"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18948538"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19520058"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20494825"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21191027"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22073189"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22660413"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="52" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19906316"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000305"/>
<sequence length="868" mass="96023" checksum="573588D1F612EC93" modified="2002-03-01" version="1">MATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPRTMPPTKPQPPARPPPPVLPANRAPSATAPSPVGAGTAAPAPSQTPGSAPPPQAQGPPYPTYPGYPGYCQMPMPMGYNPYAYGQYNMPYPPVYHQSPGQAPYPGPQQPSYPFPQPPQQSYYPQQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

